- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Abiraterone acetate (Treatment B)
Total 759 results
-
Janssen Research & Development, LLCCompleted
-
Cougar Biotechnology, Inc.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Cougar Biotechnology, Inc.Completed
-
Cougar Biotechnology, Inc.CompletedProstate NeoplasmsUnited Kingdom, United States
-
Fundación Pública Andaluza para la gestión de la...Completed
-
Janssen Research & Development, LLCCompletedHealthy ParticipantsUnited States
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedProstate CancerFrance
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
The Affiliated Hospital of Qingdao UniversityCompletedHealthy VolunteersChina
-
Cougar Biotechnology, Inc.Completed
-
AstraZenecaCompletedAdvanced Castrate-resistant Prostate Cancer CRPC | Squamous Non-Small Cell Lung Cancer sqNSCLC | Triple Negative Breast Cancer TNBCSpain, Canada, United States, United Kingdom
-
Universität des SaarlandesCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
Sun Pharmaceutical Industries LimitedCompletedProstate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
PfizerCompletedA Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804Healthy VolunteersBelgium
-
Massachusetts General HospitalUnknown
-
Cougar Biotechnology, Inc.Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed21-hydroxylase DeficiencyUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsCanada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited Kingdom
-
Zhongnan HospitalActive, not recruitingPharmacokinetic | Abiraterone Acetate | Plasma Concentration | Gene Polymorphism | Metabolic AnalysisChina
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingProstate CancerUnited States
-
Guangzhou University of Traditional Chinese MedicineCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Hongqian GuoAstraZeneca; Nanjing Chia-tai Tianqing PharmaceuticalRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate CarcinomaChina
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
PfizerCompleted
-
PfizerCompleted
-
Hospices Civils de LyonCompletedAcquired Visual Field DefectsFrance
-
PfizerCompletedHealthyUnited States
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
Novartis PharmaceuticalsCompleted
-
PfizerAstellas Pharma IncActive, not recruitingProstatic Neoplasms, Castration-ResistantUnited States
-
Aurelius OmlinUniversity Hospital, Basel, Switzerland; Cantonal Hospital of St. GallenTerminated
-
Cancer Research UKCompletedBreast CancerUnited Kingdom
-
PfizerCompleted
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCActive, not recruitingCastration-resistant Prostate CancerUnited States
-
PfizerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
University of California, San FranciscoJohnson & Johnson; Cougar Biotechnology, Inc.Completed
-
Rennes University HospitalRecruiting
-
AstraZenecaParexelCompletedCoronary Artery DiseaseUnited Kingdom
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
AbbVieCompleted